'Razmnama' is the Persian translation of which Indian epic? a)Ramayanab)Mahabahratc)Raghuvamshad)KumarsambhavaCorrect answer is option 'B'. Can you explain this answer?

EduRev

All Courses

Explore Courses UPSC Exam UPSC Test Series Free Notes EduRev Infinity

Open App

Class 1 Exam > Class 1 Questions > 'Razmnama' is the Persian translation of whic...

'Razmnama' is the Persian translation of which Indian epic?

a)
Ramayana
b)
Mahabahrat
c)
Raghuvamsha
d)
Kumarsambhava

Correct answer is option 'B'. Can you explain this answer?

Join for Free

Join for Free

Verified Answer

'Razmnama' is the Persian translation of which Indian epic? a)Ramayan...

Razmnama - The Persian Translation of Indian Epic

The Answer: B. Mahabharata
Explanation:
- The Persian translation of the Indian epic is called "Razmnama".
- The Razmnama is a Persian translation of the Mahabharata, one of the two major Sanskrit epics of ancient India.
- "Razmnama" literally translates to "Book of War" in Persian.
- The translation was commissioned by the Mughal emperor Akbar the Great in the 16th century.
- The Persian translation was done by several Persian scholars under the supervision of Abu'l Fazl, one of the most important ministers in Akbar's court.
- The Razmnama contains the stories and narratives of the Mahabharata, but with certain adaptations and additions to suit the Persian literary and cultural context.
- The Persian translation played a significant role in introducing the Mahabharata and its characters to Persian-speaking audiences.
- The Razmnama also includes beautiful illustrations depicting the scenes and characters from the Mahabharata.
- Today, the Razmnama is considered a valuable cultural and literary artifact that reflects the cross-cultural exchange between India and Persia during the Mughal period.

View all questions of this test

View all answers Start learning for free

Explore Courses for Class 1 exam

Similar Class 1 Doubts

Which of the following book is from the Hindu religion?

View answer

Directions: The passage given below is followed by a set of questions. Choose the best answer to each question.What good is vaccination? Obviously it is good for the person receiving the vaccine, if he is thus prevented from suffering from a nasty disease. More subtly, it can be good for an entire population since, if enough of its members are vaccinated, even those who are not will receive a measure of protection. That is because, with only a few susceptible individuals, the transmission of the infection cannot be maintained and the disease spread is checked. But in the case of many vaccines, there are non-medical benefits, too, in the form of costs avoided and the generation of income that would otherwise have been lost. These goods are economic. Quantifying these more general benefits is hard. But a pair of researchers from Harvard University has just tried. David Bloom and David Canning, together with Mark Weston, an independent policy consultant, have looked at two vaccination programmes and attempted to calculate the wider benefits. Their conclusions have just been published in the World Economics.Dr. Bloom and Dr. Canning believed that previous attempts to quantify the non-medical benefits of vaccination had been too narrow. These had looked at such data as the cost of a programme per life saved, but had failed to take account of recent work on the effects of health on incomes. For their study, they and Mr Weston identified how vaccination, in particular, might increase wealth.The first benefit was that healthy children are more likely to attend school and better able to learn. The second was that healthy workers are more productive. Both of these seem fairly obvious. Two other benefits, however, are less so. One being that good health promotes savings and investments. This is because healthy people both expect to live longer and actually do live longer. The other being that good health—and particularly, expectations about the good health of one’s offspring – promote the so-called demographic transition from large to small families that usually accompanies economic development. None of these factors, the researchers thought, had been properly taken account of in previous estimates of the cost-effectiveness of vaccination.To demonstrate that at least one of their ideas was correct, they turned to the Phillipines. Here, a study called the Cebu Longitudinal Health and Nutrition Survey has been going on since 1983. It follows the lives of Filipina mothers and those of their children born in 1983 and 1984. Among the data collected were the records of the vaccinations these children received as infants and also their scores in language, maths and IQ tests at the age of ten. The three researchers organized children whose social circumstances were similar into groups, depending on whether or not the children had been vaccinated against a range of diseases including measles, polio and tuberculosis. They then compared test scores between groups. They found a statistically significant difference in the language and IQ scores between otherwise comparable vaccinated and unvaccinated children. In both cases, those of the unvaccinated were lower. Since it is known for the other studies that these scores are good predictors of adult income, the researchers concluded that childhood vaccination would have significant economic benefits.In order to predict those benefits, they turned to vaccination campaign that is just beginning. The Global Alliance for Vaccines and Immunisation (GAVI) is a collaboration of governments, international organizations, vaccine-makers and charities. It is embarking on a 15-year programme to vaccinate children in 75 of the world’s poorest countries against a range of childhood diseases. The programme is scheduled to cost 13 bn dollars. First, the researchers used data from previous vaccination programmes to estimate both the reduction in mortality and the improvement in the health of the living that might be expected to flow from the new GAVI programme. Then they combined these estimates with existing data about the economic effects of health improvement in these programmes in poor countries, in particular their effects on future income. Using standard accounting methodsthey calculate that the new GAVI programme can be expected to generate an immediate rate of return of 12.4%, rising to 18% by the end of the programme. And that does not include any benefits that might come from the demographic transition. The dispassionate economic case for vaccination, therefore, looks at least as strong as the compassionate medical one. If the figures produced by Dr Bloom, Dr Canning and Mr Weston are right, it truly is an investment for the future.Q. In the given sentence highlighted in the passage, pick the part that has an error in it.

View answer

What is the main focus of Mahabharat?

View answer

Who has written Mahabharata?

View answer

Direction: The following question are accompanied by two statements (I) and (II). You have to determine which statements(s) is/are sufficient/necessary to answer the following question.A shopkeeper marked an article above the cost price and sold it after two consecutive discounts. Find the difference between the cost price and the marked price of the article.I: The shopkeeper marked the article 40% above the cost price and sold it after two consecutive discounts of ‘x’% and ‘x + 5’% respectively. In this transaction the shopkeeper had a profit of 7.1%.II: The shopkeeper marked the article ‘p’% above the cost price and sold it after two consecutive discounts of 10% and 15% respectively. In this transaction the shopkeeper had a profit of Rs. 284.

View answer

Top Courses for Class 1View all

Spelling Bee

Mental Maths

General Knowledge for Young Learners

Mathematics Olympiad for Class 1

English Grammar for Junior Classes